Today, Millennium Biotechnologies Group announced that Nutrimedica, S.A., an international nutritional supplement distributor, headquartered in Athens, Greece, has ordered its complete medical line which includes 5 separate Resurgex(r) product lines and 12 SKUs of the Company’s powdered and Ready-To-Drink formulations. The purchase order, greater than the total revenue the Company received from Greece in 2008, is valued at $487,690 and will be shipped during the first quarter of 2009.
Chief Executive Officer Mark Mirken stated, “The strong broad-based demand for the Resurgex product line in Greece supports and encourages our expectation that the product line will be successful in the international marketplace as a whole. We plan to add additional international distributors of similar size this year. Importantly, Nutrimedica has been successful in broadening the usage of the Resurgex product line beyond Oncology, into other hospital settings including Intensive Care Units and Surgery Clinics as well as the retail marketplace in Greece.”